Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin family domain containing 1 pseudogene (ENSG00000271676, also known as LOC339966) is classified as a **pseudogene**, meaning it is a nonfunctional segment of DNA that closely resembles a functional gene from the ubiquitin family but does not encode a functional protein[3][4]. Pseudogenes typically arise through the duplication or retrotransposition of functional genes but accumulate mutations that prevent their expression or translation into active proteins. Although traditionally considered nonfunctional, some pseudogenes may be transcribed into RNA and can exert regulatory functions, such as acting as microRNA decoys, RNA interference agents, or regulators of their parental gene's expression[1][3]. However, there are no known therapeutic drugs, biomarkers, or functional protein products associated with this pseudogene. It is not considered a classical drug target and primarily represents "genomic fossil" material. In rare cases, pseudogenes are implicated in disease primarily when their altered transcription modulates the function of related protein-coding genes, but there is no evidence that this is the case for LOC339966[1][4]. The presence of "pseudogene" in the name and lack of coding function means it is **not a therapeutic target** under standard definitions. **Note:** This entry is not a functional target; designation as a therapeutic target, receptor, or enzyme is incorrect. Its listing may result from a misunderstanding or overbroad gene target search[4][3].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin family domain containing 1 pseudogene (null).